Inventor

ELLEN K. KICK

Inventor

Overview

4→

Patents

2021–2026

Patent span

Human necessities

Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%

C07DHeterocyclic compounds33%

A61KPreparations for medical, dental or toiletry purposes25%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%

PatentTitleYear

12,577,206Pyrazolone formyl peptide 2 receptor agonists2026 12,565,483Oxopyrrolidine urea FPR2 agonists2026 11,708,327Phenylpyrrolidinone formyl peptide 2 receptor agonists2023 11,180,490Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2026Patents assigned to BRISTOL MYERS SQUIBB CO (4)· patent assignee history

2021–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BRISTOL MYERS SQUIBB CO	4	2021–2026

Locations

Location	Patents	Span
US	4	2021–2026